PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells (Q46502766)

22 December 2017

title

PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells (English)

1 reference

22 December 2017

1 reference

7

1 reference

22 December 2017

author name string

Felicita Baratelli

1

1 reference

22 December 2017

Kostyantyn Krysan

2

1 reference

22 December 2017

Nathalie Heuzé-Vourc'h

3

1 reference

22 December 2017

Li Zhu

4

1 reference

22 December 2017

Brian Escuadro

5

1 reference

22 December 2017

Sherven Sharma

6

1 reference

22 December 2017

Mariam Dohadwala

8

1 reference

22 December 2017

Steven M Dubinett

9

1 reference

22 December 2017

publication date

20 May 2005

1 reference

22 December 2017

Journal of Leukocyte Biology

published in

1 reference

22 December 2017

volume

78

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

555-564

1 reference

22 December 2017

Control of apoptosis and mitotic spindle checkpoint by survivin

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Cytokine-regulated expression of survivin in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Control of apoptosis during angiogenesis by survivin expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Inhibitor of apoptosis protein survivin regulates vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Prostanoid receptors: subtypes and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Cellular response to oxidative stress: signaling for suicide and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Tumor-host immune interactions and dendritic cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1004569

21 January 2018

Identifiers

DOI

10.1189/JLB.1004569

1 reference

22 December 2017

release_uo6nluyf2fhi5pr7mssxcsqmbi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uo6nluyf2fhi5pr7mssxcsqmbi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017